Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHEK1 | O14757 | 1/20 | 0.40 |
| ▸ | CYP11B2 | P19099 | 7/20 | 0.39 |
| ▸ | CYP11B1 | P15538 | 4/20 | 0.39 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.36 |
| ▸ | AR | P10275 | 1/20 | 0.35 |
| ▸ | KDM1A | O60341 | 4/20 | 0.33 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.33 |
| ▸ | NSD2 | O96028 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.33 |
| ▸ | FLT3 | P36888 | 1/20 | 0.32 |
| ▸ | USP14 | P54578 | 1/20 | 0.32 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.32 |
| ▸ | SCN10A | Q9Y5Y9 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21928418 | 0.95 | CHEK1 (0.37) | CHEK1CYP11B2CYP11B1GRM2AR | |
| SCHEMBL21928591 | 0.91 | CYP11B2 (0.39) | CHEK1CYP11B2CYP11B1GRM2AR | |
| SCHEMBL21931740 | 0.90 | CHEK1 (0.40) | CHEK1CYP11B2CYP11B1GRM2AR | |
| SCHEMBL24737200 | 0.89 | CYP1A2 (0.38) | CHEK1CYP11B2CYP11B1ALDH1A1FLT3 | |
| SCHEMBL21928615 | 0.89 | PTGER4 (0.38) | CHEK1CYP11B2CYP11B1GRM2AR | |
| SCHEMBL21929025 | 0.88 | CHEK1 (0.41) | CHEK1CYP11B2CYP11B1ARALDH1A1 | |
| SCHEMBL24737225 | 0.87 | CHEK1 (0.42) | CHEK1CYP11B2CYP11B1ARKDM1A | |
| SCHEMBL21928421 | 0.87 | CHEK1 (0.46) | CHEK1CYP11B2CYP11B1GRM2AR | |
| SCHEMBL19909499 | 0.86 | CYP11B1 (0.38) | CHEK1CYP11B2CYP11B1GRM2FLT3 | |
| SCHEMBL21929032 | 0.85 | CHEK1 (0.39) | CHEK1CYP11B2CYP11B1AR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220388960-A1 | ORGANIC MOLECULES FOR USE IN LIGHT-EMITTING DEVICES | CYNORA GMBH (DE) | 2022-12-08 | — | — | US | disclosed |
| US-20200136054-A1 | ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | SAMSUNG DISPLAY CO., LTD. (KR) | 2020-04-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200136054-A1 | ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | OR10J3, OGFR, OR51E2 | CHEK1 3808/4885CYP11B2 902/4885CYP11B1 1431/4885 |
| US-20220388960-A1 | ORGANIC MOLECULES FOR USE IN LIGHT-EMITTING DEVICES | ALDH1A2, AOX1, CYBA | CHEK1 1237/4885CYP11B2 163/4885CYP11B1 432/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.